Pages that link to "Q68100559"
Jump to navigation
Jump to search
The following pages link to Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report (Q68100559):
Displaying 50 items.
- Focus on Adoptive T Cell Transfer Trials in Melanoma (Q21328679) (← links)
- Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor (Q24312048) (← links)
- Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection (Q24561706) (← links)
- Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy (Q24596055) (← links)
- Adoptive cell transfer: a clinical path to effective cancer immunotherapy (Q24644774) (← links)
- Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes (Q24647904) (← links)
- Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes (Q24649346) (← links)
- Identification of human cancers deficient in antigen processing (Q24678495) (← links)
- Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells (Q24802970) (← links)
- Progress and controversies in developing cancer vaccines (Q24810256) (← links)
- Prion diseases: immunotargets and therapy (Q26741258) (← links)
- Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response (Q26744527) (← links)
- Current clinical immunotherapeutic approaches for head and neck cancer (Q26745411) (← links)
- Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer Cells (Q26751018) (← links)
- Predictive factors for immunotherapy in melanoma (Q26778765) (← links)
- The Evolution of T-cell Therapies for Solid Malignancies (Q26799372) (← links)
- CAR T Cell Therapy: A Game Changer in Cancer Treatment (Q26822769) (← links)
- Preclinical biosafety evaluation of cell-based therapies: emerging global paradigms (Q26829230) (← links)
- T lymphocytes targeting native receptors (Q26853345) (← links)
- Autologous therapies in dermatology (Q26859003) (← links)
- Genetically modified T cells for the treatment of malignant disease (Q26860657) (← links)
- Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy? (Q27002575) (← links)
- Clinical application of adoptive T cell therapy in solid tumors (Q27011283) (← links)
- γδ T cells for cancer immunotherapy: A systematic review of clinical trials (Q27021705) (← links)
- Nanoengineering approaches to the design of artificial antigen-presenting cells (Q27023634) (← links)
- Genetically modified T cells in cancer therapy: opportunities and challenges (Q27026627) (← links)
- Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies (Q27027243) (← links)
- Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes (Q27634698) (← links)
- IL-2/anti-IL-2 mAb immunocomplexes: A renascence of IL-2 in cancer immunotherapy? (Q28073154) (← links)
- Technical Considerations for the Generation of Adoptively Transferred T Cells in Cancer Immunotherapy (Q28073563) (← links)
- T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities (Q28074619) (← links)
- Harnessing the Microbiome to Enhance Cancer Immunotherapy (Q28088598) (← links)
- A serpin from human tumor cells with direct lymphoid immunomodulatory activity: mitogenic stimulation of human tumor-infiltrating lymphocytes (Q28290529) (← links)
- Remission of monoclonal chronic T-cell expansion associated with severe anemia (Q28325265) (← links)
- How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer (Q28727481) (← links)
- Immunosuppressive networks in the tumour environment and their therapeutic relevance (Q29619244) (← links)
- Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy (Q30310231) (← links)
- Immunity to melanoma antigens: from self-tolerance to immunotherapy (Q30440584) (← links)
- Direct identification of tumor-associated peptide antigens. (Q30469600) (← links)
- Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects (Q30525394) (← links)
- The clinical significance of tumor infiltrating lymphoctyes in breast cancer: does subtype matter? (Q31053828) (← links)
- Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR. (Q33181048) (← links)
- Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy (Q33210267) (← links)
- Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma (Q33423772) (← links)
- Prospects for the therapeutic use of anticancer vaccines (Q33588526) (← links)
- Mitogenic stimulation of human tumor-infiltrating lymphocytes by secreted factor(s) from human tumor cell lines (Q33601843) (← links)
- Strategies to genetically engineer T cells for cancer immunotherapy (Q33655849) (← links)
- Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes (Q33688441) (← links)
- CD137 agonist antibody prevents cancer recurrence: contribution of CD137 on both hematopoietic and nonhematopoietic cells (Q33722711) (← links)
- Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs) (Q33750205) (← links)